Plexiform Bioscience
Plexiform Bioscience is a US startup, founded in 2024. It has raised at least $1.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
Plexiform Bioscience has raised at least $1.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
Questions and answers
What does Plexiform Bioscience do?
Plexiform Bioscience is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Plexiform Bioscience raised?
At least $1.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Plexiform Bioscience based?
Plexiform Bioscience is registered in United States; its operating headquarters is not yet confirmed.
When was Plexiform Bioscience founded?
Plexiform Bioscience was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.